Journals / Molecular Imaging and Radionuclide Therapy / 2020 / Cilt: 29 - Sayı: 1

Hepatopulmonary Syndrome with Right-to-left Shunt in Cirrhotic Patients Using Macro-Aggregated Albumin Lung Perfusion Scan: Comparison with Contrast Echocardiography and Association with Clinical Data

Sirotik Hastalardaki Sağ-Sol Şant ile İlişkili Hepatopulmoner Sendromun Tanısında MakroAgregant Albümin Akciğer Perfüzyon Sintigrafisinin Kontrast Ekokardiyografi ile Karşılaştırılması ve Klinik Veriler ile İlişkisi

Pages
1–6
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Among coagulation factors assessed in cirrhotic patients, we found only significant correlation between HPS and prothrombin time (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: The diagnosis of hepatopulmonary syndrome (HPS) which is a common complication in cirrhotic patients is still subject to debate.
📊
Key Findings & Data:This study investigated the association of clinical findings with HPS in cirrhotic patients using macro-aggregated albumin lung perfusion scan (99mTcMAA lung scintigraphy).
💡
Conclusion & Impact:Among coagulation factors assessed in cirrhotic patients, we found only significant correlation between HPS and prothrombin time (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: The diagnosis of hepatopulmonary syndrome (HPS) which is a common complication in cirrhotic patients is still subject to debate. This study investigated the association of clinical findings with HPS in cirrhotic patients using macro-aggregated albumin lung perfusion scan (99mTcMAA lung scintigraphy). In addition, comparison between 99mTc-MAA lung scintigraphy and contrast echocardiography (CEE) in detection of HPS was also performed. Methods: In this study, 27 patients with cirrhosis underwent 99mTc-MAA lung scintigraphy and contrast echocardiography comparison CEE and the frequency of HPS was assessed in them and also was compared across the other variables. Results: The 99mTc-MAA lung scintigraphy showed HPS in 13 patients (48.1%) while CEE demonstrated HPS in 5 patients with cirrhosis (18.51%). HPS was mild in 40.74% (11/27) of the patients, and severe in only 2 patients. There was no relationship between gender, disease duration, having diagnosis of disease previously, pulmonary symptoms and Child-Pugh score variations and HPS (p>0.05). Comparison of hemodynamic indices, arterial blood gas analysis and laboratory indices between patients with and without HPS was also non-significant (p value >0.05). Among coagulation factors assessed in cirrhotic patients, we found only significant correlation between HPS and prothrombin time (p

Özet

Amaç: Sirotik hastalarda sık görülen bir komplikasyon olan hepatopulmoner sendromun (HPS) tanısı halen tartışmaya açıktır. Bu çalışmada, makroagregat albümin akciğer perfüzyon sintigrafisi (99mTc-MAA akciğer sintigrafisi) kullanılarak sirotik hastalarda klinik bulgularla HPS’nin ilişkisi araştırılmıştır. Ayrıca, HPS’nin saptanmasında 99mTc-MAA akciğer sintigrafisi ile kontrast ekokardiyografi (KE) karşılaştırılmıştır. Yöntem: Bu çalışmada, sirozlu 27 hastada 99mTc-MAA akciğer sintigrafisi ve KE karşılaştırıldı ve HPS sıklığı değerlendirildi. Ayrıca HPS’nin sıklığı ile diğer değişkenler arasındaki ilişki araştırıldı. Bulgular: 99mTc-MAA akciğer sintigrafisi 13 sirozlu hastada (%48,1) HPS’nin varlığını gösterirken, KE 5 sirozlu hastada (%18,51) gösterdi. HPS hastaların %40,74’inde (11/27) hafif, sadece 2 hastada şiddetliydi. Cinsiyet, hastalık süresi, hastalık geçmişi, akciğer semptomları ve Child skoru ile HPS arasında herhangi bir ilişki yoktu (p>0,05). Hemodinamik indeksler, arteriyel kan gazı analizi ve laboratuvar indeksleri açısından HPS’li hastalar ve HPS’li olmayan hastalar arasında fark görülmedi (p>0,05). Sirotik hastalarda değerlendirilen koagülasyon faktörleri arasında, sadece HPS ve protrombin zamanı arasında anlamlı bir korelasyon bulundu (p

🔖

Cite This Article

GHOLAMREZANEZHAD, A., TABİB, S. M., AZİZMOHAMMADİ, Z., ASSADİ, M., ALİPOUR, Z., ARMİN, A., MOHAMADİ, S. (2022). Hepatopulmonary Syndrome with Right-to-left Shunt in Cirrhotic Patients Using Macro-Aggregated Albumin Lung Perfusion Scan: Comparison with Contrast Echocardiography and Association with Clinical Data. Molecular Imaging and Radionuclide Therapy, Cilt: 29 - Sayı: 1, 1–6. https://ajindex.com/articles/581575

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Lima BL, França AV, Pazin-Filho A, Araújo WM, Martinez JA, Maciel BC, Simões MV, Terra-Filho J, Martinelli AL. Frequency, clinical characteristics, and respiratory parameter of hepatopulmonay Syndrome. Mayo Clin Proc 2004;79:42-48.
  2. Schen KP, Falrmaannn V, Madl C, Funk G, Lehr S, Kandel O, Müller C. Hepatopulmonary syndrome: prevalence and predictive value of various cut off for arterial oxygenation and their clinical consequences. Gut 2002;51:853-859.
  3. Hira HS, Kumaj T, Tyagi SK, Jain SK. A study of hepatopulmonary syndrome among patient of cirrhosis of liver and portal hypertension. Indian J Chest Dis Allied Sci 2003;45:165-171.
  4. Anond AC, Malcheryee D, Rao KS, Seth AK. Hepatopulmonary syndrome; prevalence and clinical profile. Indian J Gastroenterol 2001;20:24-27.
  5. Fallon MB, Abrams GA. Pulmonary dysfunction in chronic disease. Hepatology 2000;32:859-865.
  6. Przybyowski T, Krenke R, Fangrat A, Nasilowski J, Grabczak EM, Styczynskg G, Pruszczyk P, Krawczyk M, Chazan R. Gas exchange abnormalities in patients listed forliver transplantation. J Physiol Pharmacol 2006;57 Suppl 4:313-323. Flukiger M. Occurrence of club-shaped finger phalanges without chronicchanges in the lungs or heart. Wien Med Wochenschr 1884;34:1457-1458.
  7. Rodriguez-Roisin R, Krowka MJ, Herve P, Fallon MB. Pulmonary hepatic vascular disorders (PHD). Eur Respir J 2004; 24:861-80.
  8. Abrams GA, Jaffe CC, Hoffer PB, Binder HJ, Fallon MB. Diagnostic utility of contrast echocardiography and lung perfusion scan in patients with hepatopulmonary syndrome. Gastroenterology 1995;109:1283-1288. 10. Abrams GA, Nanda NC, Dubovsky EV, Krowka MJ, Fallon MB. Use of macro-aggregated albumin lung perfusion scan to diagnose hepatopulmonary syndrome: a new approach. Gastroenterology 1998;114:305-310. 11. Gupta NA, Abramowsky C, Pillen T, Redd D, Fasola C, Heffron T, Romero R. Pediatric hepatopulmonarys Syndrome is seen with polysplenia/ interrupted inferior vena cava and without cirrhosis. Liver Transpl 2007;13:680-686. 12. Swanson KL,Wiesner RH, Krowka MJ. Natural history of hepatopulmonary syndrome: impact of liver transplantation. Hepatology 2005;41:11221129. 13. Noli K, Solomon M, Golding F, Charron F, Ling SC. Prevalence of hepatopulmonary syndrome in children. Pediatrics 2008;121:522-527. 14. Surasi DS, Manapragada P, Bhambhvani P. Lung perfusion imaging in hepatopulmonary syndrome using (99m)Tc macroaggregated albumin. J Nucl Cardiol 2015;22:586-588. 15. El-Shabrawi MH, Omran S, Wageeh S, Isa M, Okasha S, Mohsen